TheraRadar
← Back
Data updated: Jun 28, 2026

WESTWOOD SQUIBB

Specialty
Pharmaceuticals

WESTWOOD SQUIBB is a specialty pharmaceutical company with 7 FDA-approved products.

1971
Since
7
Drugs
-
Trials
0
New Drugs (2yr)

WESTWOOD SQUIBB's Key Drugs

WESTWOOD SQUIBB's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

WESTWOOD SQUIBB's Recent FDA Approvals

New NDA/BLA approvals for WESTWOOD SQUIBB over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

WESTWOOD SQUIBB's Therapeutic Areas

Disease areas where WESTWOOD SQUIBB has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

WESTWOOD SQUIBB Pipeline Snapshot

Active clinical trials for WESTWOOD SQUIBB across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling